ISN GREEN-K Webinar: Ethical challenges for Green Nephrology: getting the priorities right

As nephrology increasingly embraces environmentally sustainable practices, clinicians must navigate the complexities of delivering high-quality care while reducing environmental impact.

This ISN Green-K webinar explores ethical imperatives and dilemmas faced by kidney care professionals.

Imperatives regard, in hierarchical sequence : health equity (i.e. universal access to dialysis care); patients’ right of choosing treatments (implying the availability of different treatments); need to guarantee the best patient outcomes, and respecting planetary health, by wise resource allocation, avoiding futility and engaging in a reevaluation of the way dialysis is performed, and  patients are involved.

The dilemmas include avoiding futility (ex. tailoring dialysis frequency to needs; reconsidering dialysate flows) versus following economic interests or being limited to (often obsolete) regulatory rules; organizing personalized care in the setting of reduced time to dedicate to the patients; combining limited resources with quality of care; setting the perimeter of care vs lifestyle interventions.

Join experts as they examine the difficult trade-offs and guide the conversation on setting ethical and clinical priorities in green nephrology.

Learning objectives:

- Identify the key imperatives in implementing sustainable kidney care practices.Explore how resource limitations and environmental goals intersect with clinical decisions.
- Discuss strategies to ensure equitable care while advancing green nephrology principles.
- Comment on how attention to sustainability may lead to reinvest in improving the overall quality of care (and not decreasing it)

Further reading:


The GREEN-K initiative was launched with support from:

image
image

Giorgina Barbara Piccoli

France

Letizia De Chiara

Italy

Dr. Letizia De Chiara is postdoctoral fellow in the laboratory of Paola Romagnani at the University of Florence, Italy. She obtained her PhD at the Molecular Biotechnology Center of Turin, Italy where she investigated the utility of novel stem cell therapies for the treatment of Acute Kidney Injury (AKI) and prevention of progression to Chronic Kidney Disease (CKD). Following the completion of her PhD studies, she moved to University College Dublin (UCD), Ireland and then she joined the Weill Cornell Medical College of New York, USA to pursue her studies on stem cell plasticity and kidney injury. In 2019, she was awarded a Marie Sklodowska-Curie Reintegration Fellowship to return to Italy. Since then, her research has focused on investigating the link between AKI and CKD development. Recently, she was awarded a L’Oreal-UNESCO for Women in Science Award for her studies on developing new prognostic markers to stratify patients at risk of progressing toward CKD following AKI. She is currently part of the Kidney International editorial board as a KI ISN fellow and she is part of the second cohort of the ISN emerging leaders

Shaifali Sandal

Canada

Key:

Complete
Failed
Available
Locked
ISN Green-K Webinar: Ethical challenges for Green Nephrology: getting the priorities right
Open to view video.  |   Closed captions available
Open to view video.  |   Closed captions available
You must register to access.